Page last updated: 2024-09-03

nifekalant hydrochloride and Aging

nifekalant hydrochloride has been researched along with Aging in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, M; Kato, T; Kobayashi, Y; Morita, N; Sato, N; Takano, T; Tanaka, K; Yasutake, M	1

Trials

1 trial(s) available for nifekalant hydrochloride and Aging

Article	Year
Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment. Journal of cardiovascular electrophysiology, 2005, Volume: 16, Issue:7 Topics: Aged; Aging; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Hemodynamics; Hospital Mortality; Humans; Male; Middle Aged; Premedication; Prognosis; Pyrimidinones; Secondary Prevention; Treatment Failure; Treatment Outcome	2005

Article

Year

Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.

Journal of cardiovascular electrophysiology, 2005, Volume: 16, Issue:7

Topics: Aged; Aging; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Hemodynamics; Hospital Mortality; Humans; Male; Middle Aged; Premedication; Prognosis; Pyrimidinones; Secondary Prevention; Treatment Failure; Treatment Outcome

2005